JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares S&P 500 Value ETF
IVE
|
+$2.05B |
| 2 |
iShares S&P 500 Growth ETF
IVW
|
+$1.92B |
| 3 |
iShares Core US Aggregate Bond ETF
AGG
|
+$1.13B |
| 4 |
iShares Russell 1000 Value ETF
IWD
|
+$1.1B |
| 5 |
State Street Health Care Select Sector SPDR ETF
XLV
|
+$1.06B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
JPMorgan BetaBuilders Japan ETF
BBJP
|
+$1.24B |
| 2 |
JPMorgan BetaBuilders Europe ETF
BBEU
|
+$1.12B |
| 3 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$989M |
| 4 |
Microsoft
MSFT
|
+$973M |
| 5 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$931M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 27.54% |
| 2 | Technology | 14.97% |
| 3 | Healthcare | 10.91% |
| 4 | Financials | 10.87% |
| 5 | Consumer Discretionary | 8.99% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
4376
ImmunityBio
IBRX
$11.1B
| $89K | ﹤0.01% |
30,937
-126,308
| -80% | -$633K |
2015 Q3
18 quarters
|
|
|
IGMS
4377
DELISTED
IGM Biosciences
IGMS
| $89K | ﹤0.01% |
1,588
-27
| -2% | -$1.18K |
2019 Q4
1 quarter
|
|
4378
State Street SPDR S&P Insurance ETF
KIE
$539M
| $89K | ﹤0.01% |
3,558
-34,506
| -91% | -$1.13M |
2017 Q2
11 quarters
|
|
4379
Direxion Daily S&P 500 Bear 3x ETF
SPXS
$322M
| $89K | ﹤0.01% |
56
+49
| +700% | +$72.8K |
2018 Q3
6 quarters
|
|
|
SPN
4380
DELISTED
Superior Energy Services, Inc.
SPN
| $88K | ﹤0.01% |
59,991
+39,807
| +197% | +$157K |
2019 Q4
1 quarter
|
|
4381
JPMorgan BetaBuilders USD High Yield Corporate Bond ETF
BBHY
$672M
| $87K | ﹤0.01% |
1,964
+8
| +0.4% | +$396 |
2016 Q4
13 quarters
|
|
4382
VanEck Rare Earth/Strategic Metals ETF
REMX
$1.83B
| $87K | ﹤0.01% |
3,077
+353
| +13% | +$12.7K |
2018 Q4
5 quarters
|
|
|
AGEN
4383
Agenus
AGEN
$379M
| $86K | ﹤0.01% |
1,794
-1,134
| -39% | -$71.2K |
2017 Q3
10 quarters
|
|
|
APLT
4384
DELISTED
Applied Therapeutics
APLT
| $86K | ﹤0.01% |
2,629
-5,789
| -69% | -$234K |
2019 Q3
2 quarters
|
|
4385
Veru
VERU
$43.3M
| $86K | ﹤0.01% |
2,617
-9,262
| -78% | -$348K |
2018 Q1
8 quarters
|
|
|
ACGN
4386
DELISTED
Aceragen Inc
ACGN
| $86K | ﹤0.01% |
3,847
-1,645
| -30% | -$44.7K |
2019 Q3
2 quarters
|
|
|
SWI
4387
DELISTED
SolarWinds Corporation Common Stock
SWI
| $86K | ﹤0.01% |
5,174
-32,901
| -86% | -$608K |
2019 Q1
4 quarters
|
|
|
VRAY
4388
DELISTED
ViewRay, Inc.
VRAY
| $85K | ﹤0.01% |
33,955
-254,274
| -88% | -$720K |
2016 Q4
13 quarters
|
|
4389
EyePoint Inc
EYPT
$275M
| $84K | ﹤0.01% |
8,205
+6,167
| +303% | +$91.5K |
2019 Q2
3 quarters
|
|
4390
JPMorgan Diversified Return International Equity ETF
JPIN
$374M
| $84K | ﹤0.01% |
1,936
-391
| -17% | -$20.3K |
2015 Q1
20 quarters
|
|
4391
Texas Pacific Land
TPL
$23.7B
| $84K | ﹤0.01% |
1,980
+45
| +2% | +$3.29K |
2018 Q2
7 quarters
|
|
4392
Titan International
TWI
$454M
| $84K | ﹤0.01% |
53,423
+30,507
| +133% | +$78.3K |
2015 Q4
17 quarters
|
|
4393
Vertiv
VRT
$98.1B
| $84K | ﹤0.01% |
9,690
-1,213,974
| -99% | -$13.4M |
2019 Q4
1 quarter
|
|
4394
Alerus Financial
ALRS
$810M
| $83K | ﹤0.01% |
4,990
+4,016
| +412% | +$80.3K |
2019 Q4
1 quarter
|
|
|
BANX
4395
ArrowMark Financial
BANX
$197M
| $83K | ﹤0.01% |
5,155
+2,650
| +106% | +$53.1K |
2017 Q1
12 quarters
|
|
4396
BlackRock Floating Rate Income Strategies Fund
FRA
$365M
| $83K | ﹤0.01% |
8,255
+618
| +8% | +$7.64K |
2017 Q4
9 quarters
|
|
|
CASI
4397
DELISTED
CASI Pharmaceuticals
CASI
| $82K | ﹤0.01% |
4,013
+961
| +31% | +$22.9K |
2017 Q2
11 quarters
|
|
4398
Intrepid Potash
IPI
$445M
| $82K | ﹤0.01% |
10,339
-17,360
| -63% | -$323K |
2017 Q4
9 quarters
|
|
4399
Innovator US Equity Power Buffer ETF August
PAUG
$1.05B
| $82K | ﹤0.01% |
3,542
-3,064
| -46% | -$76.5K |
2019 Q3
2 quarters
|
|
4400
Global X Uranium ETF
URA
$5.62B
| $82K | ﹤0.01% |
9,376
-16,220
| -63% | -$161K |
2017 Q1
12 quarters
|
|
Similar funds
JP Morgan Chase's Q1 2020 Portfolio in Review
As of Q1 2020, JP Morgan Chase held 6,012 positions worth $426B, down 21% from $536B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
JP Morgan Chase deployed $14B of net new capital in Q1 2020, opening 362 new positions and adding to 2,382 existing holdings. Its largest new stake was NextEra Energy, Inc. 5.279% Corporate Units: 1,245,017 shares worth $54.9M.
By sector, the portfolio is most concentrated in Miscellaneous at 28% of assets, down from 28% a quarter earlier, followed by Technology and Healthcare.
On the sell side, the largest reduction was JPMorgan BetaBuilders Japan ETF, an estimated $1.24B trimmed.
- JP Morgan Chase's largest Q1 2020 buy was NextEra Energy, Inc. 5.279% Corporate Units: 1,245,017 shares worth $54.9M.
- JP Morgan Chase added most to iShares S&P 500 Value ETF in Q1 2020, an estimated $2.05B increase.
- JP Morgan Chase's biggest Q1 2020 reduction was JPMorgan BetaBuilders Japan ETF, cutting an estimated $1.24B.
- JP Morgan Chase fully exited Liberty Property Trust in Q1 2020, selling an estimated $264M.
- JP Morgan Chase's ten largest holdings make up 18% of its $426B portfolio in Q1 2020.
- JP Morgan Chase opened 362 new positions and closed 692 in Q1 2020.
- JP Morgan Chase's portfolio value fell 21% quarter-over-quarter to $426B.
Based on JP Morgan Chase's 13F filing for Q1 2020, filed 12 May 2020.